NCT06525636 - A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 9, 2024

Primary Completion Date

February 11, 2028

Study Completion Date

May 10, 2028

Conditions

X-linked Hypophosphatemia

Interventions

DRUG

KK8123

Subcutaneous administration

Trial Locations (8)

NOT_YET_RECRUITING

Institute of Osteology and Biomechanics (IOBM), Hamburg

NOT_YET_RECRUITING

Hospital Universitario La Paz, Madrid

RECRUITING

Vanderbilt University Medical Center, Nashville

NOT_YET_RECRUITING

Indiana University School of Medicine University Hospital, Indianapolis

NOT_YET_RECRUITING

University of California - San Francisco, San Francisco

NOT_YET_RECRUITING

CHU le Kremlin Bicetre, Paris

NOT_YET_RECRUITING

University of Wuerzburg, Würzburg

RECRUITING

Yale Center for XLH/ Yale University School of Medicine, New Haven